FY 2020 Ending the HIV Epidemic - Primary Care HIV Prevention (PCHP) HRSA-20-091 Triannual Progress Report Guide

Overview

The purpose of Ending the HIV Epidemic - Primary Care HIV Prevention (PCHP) supplemental funding is to expand HIV prevention services that decrease the risk of HIV transmission in geographic locations identified by Ending the HIV Epidemic in the U.S., focusing on supporting access to and use of pre-exposure prophylaxis (PrEP). Objectives for this supplemental funding opportunity include a focus on outreach to engage new and existing patients for the prevention of HIV, conducting HIV testing to include offering of PrEP, making linkages to treatment for HIV positive patients, establishing new or enhancing existing partnerships, and increasing personnel to support ending the HIV epidemic.

Year 2 Reporting

PCHP award recipients are required to report their progress through triannual progress updates. PCHP progress updates require submitting quantitative and qualitative data, with brief narrative descriptions of progress including successes and lessons learned. All quantitative reporting measures align with Uniform Data System (UDS) data measures referenced in the 2021 UDS Manual. This guide will assist you in completing your FY 2020 PCHP-Year 2 progress updates.

Progress Report Questions - Qualitative Measures

For each of the following PHCP objectives, provide a status update (i.e., completed, in progress or planned), and narratively describe successes and lessons learned about the activities supported with this funding:

  • PrEP Prescribing and PrEP Use
  • Outreach
  • HIV Testing
  • Workforce Development

Also narratively describe if you have/had any:

  • Changes from your originally approved PCHP application? If so, attach an updated project/activities plan and budget at the end of the progress report, and
  • Issues or barriers in using your PCHP funding and/or implementing the planned activities, as described in your approved PCHP application?

Progress Report Questions - Quantitative Measures

HIV Testing

Report all HIV Testing visits, patients, diagnoses, and follow up numbers conducted by the health center during the reporting period, regardless of funding source.

Reporting Measure UDS Manual Reference Data Entry
Number of health center visits during which an HIV test was performed. UDS Table 6A: Selected Diagnoses and Services Rendered, Line 21, Column a Enter the total number of health center visits during which an HIV test was performed from 3/1/2020 to the end of the current reporting period.
Number of patients tested for HIV. UDS Table 6A: Selected Diagnoses and Services Rendered, Line 21, Column b Enter the total number of patients tested for HIV from 3/1/2020 to the end of the current reporting period.
Number of patients with a documented HIV test performed between the ages of 15 and 65 years. UDS Table 6B: Quality of Care Measures, Line 20a, Column c Enter the total number of patients aged 15-65 years with a documented HIV test from 3/1/2020 to the end of the current reporting period. See the numerator description for this measure.
Number of new HIV diagnoses made. UDS Table 6B: Quality of Care Measures, Line 20, Column a Enter the total number of new HIV diagnoses made by the health center from 3/1/2020 to the end of the current reporting period.
Number of patients newly diagnosed with HIV who were seen for follow up treatment within 30 days of diagnosis.

UDS Table 6B: Quality of Care Measures, Line 20, Column c

Note this is a revised measure with the follow up treatment timeframe changed from 90 to 30 days.

Enter the total number of patients newly diagnosed with HIV who were seen for follow up treatment within 30 days of diagnosis from 3/1/2020 to the end of the current reporting period.

HIV PrEP Prescriptions

Reporting Measure UDS Manual Reference Data Entry
Number of patients at risk for HIV who test negative for HIV and received a PrEP prescription. UDS Table 6A: Selected Diagnoses and Services Rendered, Line 21e, Column b Enter the total number of patients at risk for HIV who were prescribed PrEP from 3/1/2020 to the end of the current reporting period.

Technical Assistance Resources

Date Last Reviewed:  July 2021